AM630

Published date: 2017-06-23 11:00:46
AM630 Structure
Share to Facebook Share to Twitter Share to Linkedin
Name AM630 CAS# 164178-33-0
Price ￥500.0/1g Purity 97.0%
Stocking
Period		 1 Day Stock In Stock
 Detail Product Information
Chemical & Physical Properties:
CAS Number: 164178-33-0
Name: AM630
Molecular Formula: C23H25IN2O3
Molecular Weight: 504.361
Density: 1.5±0.1 g/cm3
Boiling Point: 605.9±55.0 °C at 760 mmHg
Melting Point: N/A
Flash Point: 320.3±31.5 °C
Supplier/Manufacture

KWX Biopharmaceuticals. Inc.

Chemsrc Level: Unverified
Tel: +86635-6171816
Address: Liaocheng city in shandong province high-tech zone Dr South road no. 6 in the entrepreneurial park
Area: China
Contact: Mike Zhang
Contact Phone #: +86-18563501672
Email: zangguoyan@126.com
Website: http://www.kwxyy.com/
Major Market:
Annual Trade Volume:
Foreign Trade % of Sales:
Major partners:
The company is located in Liaocheng tech Industrial Development Zone, the existing total assets of 18 million yuan, development and production area of ​​3,600 square meters, has 40 employees, has a domestic first-class laboratory and production equipment. The company laboratory is the key municipal engineering laboratories and enterprise technology centers. Company R & D, production of high-end pharmaceutical intermediates, these projects are in the national strategic emerging industry directory, are supported by the state, while the company also both outsourcing and technology services business. The company has a technical, professional and reasonable age structure, the domestic first-class R & D team composed of 32 people, are college or higher, the team has 3 doctors, Dr. Cheng Penghu Fengya Bing is Dr. returnees, Dr. Liu Haitao 211 domestic universities , master's 12 people. Company and Beijing University, Shandong University, Liaocheng University has established technical cooperation relations and realize the combination of production and research and technical personnel to provide security for the future development. Pharmaceutical intermediates and high-end market prospects are very bright, the technical barriers to trade, less domestic and foreign research institutions, research and development projects are urgently needed products on the market, the market potential and high added value. Dr. Cheng technology leader for many years engaged in research and development of new drugs and pharmaceutical intermediates in overseas mature technology and results. Technology and market security. Current research and development of products of the project is 3.1 class anticancer drug bosutinib and key intermediates, the project Habitat leading international level. And Shandong Lukang Pharmaceutical Group Co., Ltd. Clover established long-term relations of cooperation, make full use of their equipment and the comprehensive strength advantage, the company responsible for the development and production of some products kg class, Lukang Clover responsible for amplification, and product industry of. The company plans a total investment of 52.4 million yuan, to achieve development and production of multiple projects. Has now completed an investment of 16 million yuan, bosutinib *** Realized income of 800 million, 4.3 million yuan in profits and taxes. Next plans to invest 28 million yuan, with the East China University of Technology Professor WEI Dong-Zhi Lu Hua Institute to develop, produce high-end pharmaceutical intermediates project microbial green transformation. Major R & D Febuxostat Intermediates, sitagliptin biological pharmaceutical intermediates and other high-end products are mainly used for cancer, diabetes, cardiovascular disease and so on. At the same time focus on the completion of the provincial engineering technology research center. The project is expected to completed and put into production in August 2016, after the completion of the project will realize an annual income of 100 million yuan, the annual tax amount could reach 20 million yuan. After 3--4 year rolling development, investment will increase to 2-5 billion yuan output value of up to 10 billion yuan, profits can be achieved 1-2 billion.
Top Suppliers:

Get all suppliers by the below link:

AM630 suppliers

Price: $99/10mM*1mLinDMSO
Price from the other suppliers:
2024-07-15 AM630
Price: Inquiry
2022-11-29 Iodopravadoline(AM-630)
Price: ￥Inquiry
2020-01-06 Iodopravadoline(AM-630)
Price: $450.0
2021-07-26 (6-IODO-2-METHYL-1-(2-MORPHOLINOETHYL)-1H-INDOL-3-YL)(4-METHOXYPHENYL)METHANONE
Price: $Inquiry
2023-09-20 AM630
Price: ￥Inquiry
2021-05-10 AM630
Price: ￥Inquiry

Get all price from the following link:

AM630price

Related product price:
AM630 price is ￥500.0/1g. Find complete details about AM630 product information includes price/quote, purity, stocking period etc. from KWX Biopharmaceuticals. Inc.>>Mobile(AMP) version: AM630 Price from Supplier Brand KWX Biopharmaceuticals. Inc.

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved